Marian Kruszynski

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin

Marian Kruszynski, Bernard Lammek, Maurice Manning et al. · Journal of Medicinal Chemistry · 1980 · 448 citations

Neuropeptides, Altmetric Attention Score, Pharmacotherapy +20

Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin

Maurice Manning, Marian Kruszynski, Krzysztof Bańkowski et al. · Journal of Medicinal Chemistry · 1989 · 106 citations

No requirement of cyclic conformation of antagonists in binding to vasopressin receptors

M. Manning, Jacek Przybylski, Aleksandra Olma et al. · Nature · 1987 · 76 citations

Molecular Physiology, Signal Transduction, Biochemistry +12

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches

Sheng‐Jiun Wu, Albert Schmidt, E. Beil et al. · Journal of General Virology · 2007 · 53 citations

Vaccination, Ch101f Escape, Molecular Virology +15

Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs

Randall J. Brezski, Jennifer L. Luongo, Diane Petrone et al. · The Journal of Immunology · 2008 · 47 citations · Full text